A potential association between IL‐3 and type I and III interferons in systemic lupus erythematosus

Abstract Objectives Plasmacytoid dendritic cells (pDCs), through the production of type 1 interferons (IFNs) and other cytokines, are major contributors to systemic lupus erythematosus (SLE) pathogenesis. IL‐3 promotes pDC survival, but its role in SLE is not well characterised. This study investiga...

Full description

Bibliographic Details
Main Authors: Shereen Oon, Katherine Monaghan, Milica Ng, Alberta Hoi, Eric Morand, Gino Vairo, Eugene Maraskovsky, Andrew D Nash, Ian P Wicks, Nicholas J Wilson
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Clinical & Translational Immunology
Subjects:
Online Access:https://doi.org/10.1002/cti2.1097
_version_ 1818032485890523136
author Shereen Oon
Katherine Monaghan
Milica Ng
Alberta Hoi
Eric Morand
Gino Vairo
Eugene Maraskovsky
Andrew D Nash
Ian P Wicks
Nicholas J Wilson
author_facet Shereen Oon
Katherine Monaghan
Milica Ng
Alberta Hoi
Eric Morand
Gino Vairo
Eugene Maraskovsky
Andrew D Nash
Ian P Wicks
Nicholas J Wilson
author_sort Shereen Oon
collection DOAJ
description Abstract Objectives Plasmacytoid dendritic cells (pDCs), through the production of type 1 interferons (IFNs) and other cytokines, are major contributors to systemic lupus erythematosus (SLE) pathogenesis. IL‐3 promotes pDC survival, but its role in SLE is not well characterised. This study investigated serum IL‐3 and IFN levels, and a whole blood ‘IL‐3 gene signature’, in human SLE. Methods Serum cytokine levels were measured by ELISA in n = 42 SLE patients, and n = 44 healthy donors. IL‐3‐regulated genes were determined by RNASeq of healthy donor whole blood cells (WBCs) stimulated in vitro with IL‐3 for 6 or 24 h. Whole blood cell RNASeq analysis was undertaken in a separate cohort of n = 31 SLE patients, and n = 28 healthy donors. Results Serum IL‐3 levels correlated with IFNα (r = 0.612, 95% CI 0.455–0.733, P < 0.001) and type III IFN (r = 0.585, 95% CI 0.406–0.720, P < 0.0001). IL‐3 stimulation of WBC in vitro altered 794 genes (−1 ≥ logFC ≥ 1, FDR < 0.05), of which 35 overlapped with genes differentially expressed between SLE and healthy donors. These 35 genes were expressed in 27/31 SLE donors, revealing the presence of an ‘IL‐3 gene signature’. There was strong correlation between the IL‐3 signature and an IFN signature, as determined by hierarchical clustering of the 500 most variable genes in SLE donors (r = 0.939, 95% CI 0.898–0.964, P < 0.0001). Conclusion A dual IL‐3/IFN gene signature is a feature of SLE. An association between IL‐3 and IFN raises the possibility that dual blockade of IL‐3 and IFN may be especially useful for SLE patients with this dual cytokine gene signature.
first_indexed 2024-12-10T06:08:08Z
format Article
id doaj.art-dc33ae9259a9457d941114886e24feff
institution Directory Open Access Journal
issn 2050-0068
language English
last_indexed 2024-12-10T06:08:08Z
publishDate 2019-01-01
publisher Wiley
record_format Article
series Clinical & Translational Immunology
spelling doaj.art-dc33ae9259a9457d941114886e24feff2022-12-22T01:59:39ZengWileyClinical & Translational Immunology2050-00682019-01-01812n/an/a10.1002/cti2.1097A potential association between IL‐3 and type I and III interferons in systemic lupus erythematosusShereen Oon0Katherine Monaghan1Milica Ng2Alberta Hoi3Eric Morand4Gino Vairo5Eugene Maraskovsky6Andrew D Nash7Ian P Wicks8Nicholas J Wilson9The Walter and Eliza Hall Institute of Medical Research Parkville VIC AustraliaCSL Limited Parkville VIC AustraliaCSL Limited Parkville VIC AustraliaMonash University Melbourne VIC AustraliaMonash University Melbourne VIC AustraliaCSL Limited Parkville VIC AustraliaThe University of Melbourne Parkville VIC AustraliaThe University of Melbourne Parkville VIC AustraliaThe Walter and Eliza Hall Institute of Medical Research Parkville VIC AustraliaThe University of Melbourne Parkville VIC AustraliaAbstract Objectives Plasmacytoid dendritic cells (pDCs), through the production of type 1 interferons (IFNs) and other cytokines, are major contributors to systemic lupus erythematosus (SLE) pathogenesis. IL‐3 promotes pDC survival, but its role in SLE is not well characterised. This study investigated serum IL‐3 and IFN levels, and a whole blood ‘IL‐3 gene signature’, in human SLE. Methods Serum cytokine levels were measured by ELISA in n = 42 SLE patients, and n = 44 healthy donors. IL‐3‐regulated genes were determined by RNASeq of healthy donor whole blood cells (WBCs) stimulated in vitro with IL‐3 for 6 or 24 h. Whole blood cell RNASeq analysis was undertaken in a separate cohort of n = 31 SLE patients, and n = 28 healthy donors. Results Serum IL‐3 levels correlated with IFNα (r = 0.612, 95% CI 0.455–0.733, P < 0.001) and type III IFN (r = 0.585, 95% CI 0.406–0.720, P < 0.0001). IL‐3 stimulation of WBC in vitro altered 794 genes (−1 ≥ logFC ≥ 1, FDR < 0.05), of which 35 overlapped with genes differentially expressed between SLE and healthy donors. These 35 genes were expressed in 27/31 SLE donors, revealing the presence of an ‘IL‐3 gene signature’. There was strong correlation between the IL‐3 signature and an IFN signature, as determined by hierarchical clustering of the 500 most variable genes in SLE donors (r = 0.939, 95% CI 0.898–0.964, P < 0.0001). Conclusion A dual IL‐3/IFN gene signature is a feature of SLE. An association between IL‐3 and IFN raises the possibility that dual blockade of IL‐3 and IFN may be especially useful for SLE patients with this dual cytokine gene signature.https://doi.org/10.1002/cti2.1097cytokinesgene signatureimmunological disordersinterferonsinterleukin-3systemic lupus erythematosus
spellingShingle Shereen Oon
Katherine Monaghan
Milica Ng
Alberta Hoi
Eric Morand
Gino Vairo
Eugene Maraskovsky
Andrew D Nash
Ian P Wicks
Nicholas J Wilson
A potential association between IL‐3 and type I and III interferons in systemic lupus erythematosus
Clinical & Translational Immunology
cytokines
gene signature
immunological disorders
interferons
interleukin-3
systemic lupus erythematosus
title A potential association between IL‐3 and type I and III interferons in systemic lupus erythematosus
title_full A potential association between IL‐3 and type I and III interferons in systemic lupus erythematosus
title_fullStr A potential association between IL‐3 and type I and III interferons in systemic lupus erythematosus
title_full_unstemmed A potential association between IL‐3 and type I and III interferons in systemic lupus erythematosus
title_short A potential association between IL‐3 and type I and III interferons in systemic lupus erythematosus
title_sort potential association between il 3 and type i and iii interferons in systemic lupus erythematosus
topic cytokines
gene signature
immunological disorders
interferons
interleukin-3
systemic lupus erythematosus
url https://doi.org/10.1002/cti2.1097
work_keys_str_mv AT shereenoon apotentialassociationbetweenil3andtypeiandiiiinterferonsinsystemiclupuserythematosus
AT katherinemonaghan apotentialassociationbetweenil3andtypeiandiiiinterferonsinsystemiclupuserythematosus
AT milicang apotentialassociationbetweenil3andtypeiandiiiinterferonsinsystemiclupuserythematosus
AT albertahoi apotentialassociationbetweenil3andtypeiandiiiinterferonsinsystemiclupuserythematosus
AT ericmorand apotentialassociationbetweenil3andtypeiandiiiinterferonsinsystemiclupuserythematosus
AT ginovairo apotentialassociationbetweenil3andtypeiandiiiinterferonsinsystemiclupuserythematosus
AT eugenemaraskovsky apotentialassociationbetweenil3andtypeiandiiiinterferonsinsystemiclupuserythematosus
AT andrewdnash apotentialassociationbetweenil3andtypeiandiiiinterferonsinsystemiclupuserythematosus
AT ianpwicks apotentialassociationbetweenil3andtypeiandiiiinterferonsinsystemiclupuserythematosus
AT nicholasjwilson apotentialassociationbetweenil3andtypeiandiiiinterferonsinsystemiclupuserythematosus
AT shereenoon potentialassociationbetweenil3andtypeiandiiiinterferonsinsystemiclupuserythematosus
AT katherinemonaghan potentialassociationbetweenil3andtypeiandiiiinterferonsinsystemiclupuserythematosus
AT milicang potentialassociationbetweenil3andtypeiandiiiinterferonsinsystemiclupuserythematosus
AT albertahoi potentialassociationbetweenil3andtypeiandiiiinterferonsinsystemiclupuserythematosus
AT ericmorand potentialassociationbetweenil3andtypeiandiiiinterferonsinsystemiclupuserythematosus
AT ginovairo potentialassociationbetweenil3andtypeiandiiiinterferonsinsystemiclupuserythematosus
AT eugenemaraskovsky potentialassociationbetweenil3andtypeiandiiiinterferonsinsystemiclupuserythematosus
AT andrewdnash potentialassociationbetweenil3andtypeiandiiiinterferonsinsystemiclupuserythematosus
AT ianpwicks potentialassociationbetweenil3andtypeiandiiiinterferonsinsystemiclupuserythematosus
AT nicholasjwilson potentialassociationbetweenil3andtypeiandiiiinterferonsinsystemiclupuserythematosus